Here’s what you should know:
1. Motus filed its IPO in January hoping to raise $28.8 million.
2. Trading was slated to begin anywhere between $5 to $7, with experts predicting a higher end IPO. After initial returns, Motus cut trading from $6 to $5, reducing the total amount of offered shares from 4.3 million to 3.5 million.
3. Motus is trading under the symbol MOTS.
4. Motus is using the money to commercialize its Pure-Vu colonoscopy preparation system.
More articles on supply chain:
Former Surgery Partners CEO resigns from board & more — 8 ASC company key notes
5 tips to improve ASC implant payments
Driscoll Children’s Hospital raises $980k for new pediatric ICU, outpatient surgery center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.